Impaired Sensitivity to Thyroid Hormones is Associated with Mild Cognitive Impairment in Euthyroid Patients with Type 2 Diabetes

References

• Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98. doi:10.1038/nrendo.2017.151
   PubMed Web of Science ®Google Scholar
• Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14(10):591–604. doi:10.1038/s41574-018-0048-7
   PubMed Web of Science ®Google Scholar
• Roberts RO, Knopman DS, Geda YE, et al. Association of diabetes with amnestic and nonamnestic mild cognitive impairment. Alzheimers Dement. 2014;10(1):18–26. doi:10.1016/j.jalz.2013.01.001
   PubMed Web of Science ®Google Scholar
• Biessels GJ, Strachan MW, Visseren FL, Kappelle LJ, Whitmer RA. Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol. 2014;2(3):246–255. doi:10.1016/S2213-8587(13)70088-3
   PubMed Web of Science ®Google Scholar
• Sawicka-Gutaj N, Zawalna N, Gut P, Ruchala M. Relationship between thyroid hormones and central nervous system metabolism in physiological and pathological conditions. Pharmacol Rep. 2022;74(5):847–858. doi:10.1007/s43440-022-00377-w
   PubMed Web of Science ®Google Scholar
• Accorroni A, Chiellini G, Origlia N. Effects of thyroid hormones and their metabolites on learning and memory in normal and pathological conditions. Curr Drug Metab. 2017;18(3):225–236. doi:10.2174/1389200218666170116112407
   PubMed Web of Science ®Google Scholar
• Khaleghzadeh-Ahangar H, Talebi A, Mohseni-Moghaddam P. Thyroid disorders and development of cognitive impairment: a Review Study. Neuroendocrinology. 2022;112(9):835–844. doi:10.1159/000521650
   PubMed Web of Science ®Google Scholar
• Eslami-Amirabadi M, Sajjadi SA. The relation between thyroid dysregulation and impaired cognition/behaviour: an integrative review. J Neuroendocrinol. 2021;33(3):e12948. doi:10.1111/jne.12948
   PubMed Web of Science ®Google Scholar
• Folkestad L, Brandt F, Lillevang-Johansen M, Brix TH, Hegedus L. Graves’ disease and toxic nodular goiter, aggravated by duration of hyperthyroidism, are associated with Alzheimer’s and vascular dementia: a registry-based long-term follow-up of two large cohorts. Thyroid. 2020;30(5):672–680. doi:10.1089/thy.2019.0672
   PubMed Web of Science ®Google Scholar
• Wieland DR, Wieland JR, Wang H, et al. Thyroid disorders and dementia risk: a Nationwide Population-Based Case-Control Study. Neurology. 2022;99(7):e679–e687. doi:10.1212/WNL.0000000000200740
   PubMed Web of Science ®Google Scholar
• Kalmijn S, Mehta KM, Pols HA, Hofman A, Drexhage HA, Breteler MM. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol. 2000;53(6):733–737. doi:10.1046/j.1365-2265.2000.01146.x
   PubMed Web of Science ®Google Scholar
• Quinlan P, Horvath A, Wallin A, Svensson J. Low serum concentration of free triiodothyronine (FT3) is associated with increased risk of Alzheimer’s disease. Psychoneuroendocrinology. 2019;99:112–119. doi:10.1016/j.psyneuen.2018.09.002
   PubMed Web of Science ®Google Scholar
• Wu Y, Pei Y, Wang F, Xu D, Cui W. Higher FT4 or TSH below the normal range are associated with increased risk of dementia: a meta-analysis of 11 studies. Sci Rep. 2016;6:31975. doi:10.1038/srep31975
   PubMed Web of Science ®Google Scholar
• Hogervorst E, Huppert F, Matthews FE, Brayne C. Thyroid function and cognitive decline in the MRC Cognitive Function and Ageing Study. Psychoneuroendocrinology. 2008;33(7):1013–1022. doi:10.1016/j.psyneuen.2008.05.008
   PubMed Web of Science ®Google Scholar
• Marouli E, Yusuf L, Kjaergaard AD, et al. Thyroid function and the risk of Alzheimer’s disease: a Mendelian Randomization Study. Thyroid. 2021;31(12):1794–1799. doi:10.1089/thy.2021.0321
   PubMed Web of Science ®Google Scholar
• Chaker L, Wolters FJ, Bos D, et al. Thyroid function and the risk of dementia: the Rotterdam Study. Neurology. 2016;87(16):1688–1695. doi:10.1212/WNL.0000000000003227
   PubMed Web of Science ®Google Scholar
• van Osch LA, Hogervorst E, Combrinck M, Smith AD. Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease. Neurology. 2004;62(11):1967–1971. doi:10.1212/01.wnl.0000128134.84230.9f
   PubMed Web of Science ®Google Scholar
• Johansson P, Almqvist EG, Johansson JO, et al. Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer’s disease. Psychoneuroendocrinology. 2013;38(7):1058–1066. doi:10.1016/j.psyneuen.2012.10.012
   PubMed Web of Science ®Google Scholar
• van Boxtel MP, Menheere PP, Bekers O, Hogervorst E, Jolles J, van Boxtel MPJ. Thyroid function, depressed mood, and cognitive performance in older individuals: the Maastricht Aging Study. Psychoneuroendocrinology. 2004;29(7):891–898. doi:10.1016/j.psyneuen.2003.08.002
   PubMed Web of Science ®Google Scholar
• van Vliet NA, van Heemst D, Almeida OP, et al. Association of thyroid dysfunction with cognitive function: an individual participant data analysis. JAMA Intern Med. 2021;181(11):1440–1450. doi:10.1001/jamainternmed.2021.5078
   PubMed Web of Science ®Google Scholar
• Stern RA, Davis JD, Rogers BL, et al. Preliminary study of the relationship between thyroid status and cognitive and neuropsychiatric functioning in euthyroid patients with Alzheimer dementia. Cogn Behav Neurol. 2004;17(4):219–223.
   PubMedGoogle Scholar
• Sun H, Zhu W, Liu J, An Y, Wang Y, Wang G. Reduced sensitivity to thyroid hormones is associated with high remnant cholesterol levels in Chinese euthyroid adults. J Clin Endocrinol Metab. 2022;108(1):166–174. doi:10.1210/clinem/dgac523
   PubMedGoogle Scholar
• Laclaustra M, Moreno-Franco B, Lou-Bonafonte JM, et al. Impaired sensitivity to thyroid hormones is associated with diabetes and metabolic syndrome. Diabetes Care. 2019;42(2):303–310. doi:10.2337/dc18-1410
   PubMed Web of Science ®Google Scholar
• Jostel A, Ryder WD, Shalet SM. The use of thyroid function tests in the diagnosis of hypopituitarism: definition and evaluation of the TSH index. Clin Endocrinol. 2009;71(4):529–534. doi:10.1111/j.1365-2265.2009.03534.x
   PubMed Web of Science ®Google Scholar
• Yagi H, Pohlenz J, Hayashi Y, Sakurai A, Refetoff S. Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3’-triiodothyroinine binding affinity. J Clin Endocrinol Metab. 1997;82(5):1608–1614. doi:10.1210/jcem.82.5.3945
   PubMed Web of Science ®Google Scholar
• Mehran L, Delbari N, Amouzegar A, Hasheminia M, Tohidi M, Azizi F. Reduced sensitivity to thyroid hormone is associated with diabetes and hypertension. J Clin Endocrinol Metab. 2022;107(1):167–176. doi:10.1210/clinem/dgab646
   PubMed Web of Science ®Google Scholar
• Lai S, Li J, Wang Z, Wang W, Guan H. Sensitivity to thyroid hormone indices are closely associated with NAFLD. Front Endocrinol. 2021;12:766419. doi:10.3389/fendo.2021.766419
   PubMed Web of Science ®Google Scholar
• Ding X, Wang Y, Liu J, Wang G. Impaired sensitivity to thyroid hormones is associated with elevated homocysteine levels in the euthyroid population. J Clin Endocrinol Metab. 2022;107(9):e3731–e3737. doi:10.1210/clinem/dgac371
   PubMed Web of Science ®Google Scholar
• Sun Y, Teng D, Zhao L, et al. Impaired sensitivity to thyroid hormones is associated with hyperuricemia, obesity, and cardiovascular disease risk in subjects with subclinical hypothyroidism. Thyroid. 2022;32(4):376–384. doi:10.1089/thy.2021.0500
   PubMed Web of Science ®Google Scholar
• American Diabetes A. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13–S27. doi:10.2337/dc18-S002
   PubMedGoogle Scholar
• Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270–279. doi:10.1016/j.jalz.2011.03.008
   PubMed Web of Science ®Google Scholar
• Yu J, Li J, Huang X. The Beijing version of the Montreal cognitive assessment as a brief screening tool for mild cognitive impairment: a community-based study. BMC Psychiatry. 2012;12(1):156. doi:10.1186/1471-244X-12-156
   PubMed Web of Science ®Google Scholar
• Tan ZS, Vasan RS. Thyroid function and Alzheimer’s disease. J Alzheimers Dis. 2009;16(3):503–507. doi:10.3233/JAD-2009-0991
   PubMed Web of Science ®Google Scholar
• Koromilas C, Liapi C, Schulpis KH, Kalafatakis K, Zarros A, Tsakiris S. Structural and functional alterations in the hippocampus due to hypothyroidism. Metab Brain Dis. 2010;25(3):339–354. doi:10.1007/s11011-010-9208-8
   PubMed Web of Science ®Google Scholar
• Chaalal A, Poirier R, Blum D, Laroche S, Enderlin V. Thyroid hormone supplementation restores spatial memory, hippocampal markers of neuroinflammation, plasticity-related signaling molecules, and beta-amyloid peptide load in hypothyroid Rats. Mol Neurobiol. 2019;56(1):722–735. doi:10.1007/s12035-018-1111-z
   PubMed Web of Science ®Google Scholar
• Cooke GE, Mullally S, Correia N, O’Mara SM, Gibney J. Hippocampal volume is decreased in adults with hypothyroidism. Thyroid. 2014;24(3):433–440. doi:10.1089/thy.2013.0058
   PubMed Web of Science ®Google Scholar
• Zhang H, Yang S, Zhu W, et al. Free triiodothyronine levels are related to executive function and scene memory in type 2 diabetes mellitus patients without diagnosed thyroid diseases. Diabetes Metab Syndr Obes. 2022;15:1041–1050. doi:10.2147/DMSO.S355656
   PubMed Web of Science ®Google Scholar
• Ortiga-Carvalho TM, Chiamolera MI, Pazos-Moura CC, Wondisford FE. Hypothalamus-pituitary-thyroid axis. Compr Physiol. 2016;6(3):1387–1428. doi:10.1002/cphy.c150027
   PubMed Web of Science ®Google Scholar
• Visser WE, van Mullem AA, Visser TJ, Peeters RP. Different causes of reduced sensitivity to thyroid hormone: diagnosis and clinical management. Clin Endocrinol. 2013;79(5):595–605. doi:10.1111/cen.12281
   PubMed Web of Science ®Google Scholar
• McDonald MP, Wong R, Goldstein G, Weintraub B, Cheng SY, Crawley JN. Hyperactivity and learning deficits in transgenic mice bearing a human mutant thyroid hormone beta1 receptor gene. Learn Mem. 1998;5(4–5):289–301. doi:10.1101/lm.5.4.289
   PubMed Web of Science ®Google Scholar
• Hauser P, Zametkin AJ, Martinez P, et al. Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. N Engl J Med. 1993;328(14):997–1001. doi:10.1056/NEJM199304083281403
   PubMed Web of Science ®Google Scholar
• Quinlan P, Horvath A, Eckerstrom C, Wallin A, Svensson J. Altered thyroid hormone profile in patients with Alzheimer’s disease. Psychoneuroendocrinology. 2020;121:104844. doi:10.1016/j.psyneuen.2020.104844
   PubMed Web of Science ®Google Scholar
• McAninch EA, Rajan KB, Evans DA, et al. A common DIO2 polymorphism and Alzheimer disease dementia in African and European Americans. J Clin Endocrinol Metab. 2018;103(5):1818–1826. doi:10.1210/jc.2017-01196
   PubMed Web of Science ®Google Scholar
• Castagna MG, Dentice M, Cantara S, et al. DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients. J Clin Endocrinol Metab. 2017;102(5):1623–1630. doi:10.1210/jc.2016-2587
   PubMed Web of Science ®Google Scholar
• Luo M, Zhou XH, Zou T, Keyim K, Dong LM. Type II deiodinase polymorphisms and serum thyroid hormone levels in patients with mild cognitive impairment. Genet Mol Res. 2015;14(2):5407–5416. doi:10.4238/2015.May.22.10
   PubMed Web of Science ®Google Scholar
• Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2001;56(9):1143–1153. doi:10.1212/wnl.56.9.1143
   PubMed Web of Science ®Google Scholar